Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
NCT Number: NCT01149876
The purpose of this study is to determine whether a topical Nu Skin product with or without a galvanic spa device improves brown spots on the face. The Nu Skin product will be compared to an over the counter moisturizer and tretinoin cream.
Looking for future studies?
Notify Me25 year–55 year
Female
Interventional
Phase 4
Boston, Massachusetts, 02114, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Thin layer of Nu Skin product applied to face.
Cosmetic instrument with topical Nu Skin product. Thin layer of Nu Skin product applied to face followed by galvanic, used for 3 minutes.
Thin layer of tretinoin applied to face.
Thin layer of CeraVe applied to face.
Time frame: baseline to 16 weeks
Primary outcome measure will be change in hyperpigmentation of baseline compared to week 16.
Hyperpigmentation will be measured clinically using a 0-6 scale where 0 is no hyperpigmentation and 6 is very severe hyperpigmentation.
Time frame: baseline to week 16
Secondary outcome measures will be change in rhytides of baseline compared to week 16.
Rhytides will be assessed clinically using a 0-6 scale where 0 is no lines and 6 is very deep lines.
Massachusetts General Hospital
Other
A Single Blind, Placebo Controlled Trial to Evaluate Effects of a Study Medication, a Nu Skin Lightening Product With and Without Iontophoresis vs Tretinoin Cream vs Vehicle Control for Facial Hyperpigmentation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07725900
Dry Skin, Erythema
Semarang, Central Java, Indonesia
View Trial DetailsNCT07722351
Hyperpigmentation, Melanosis
Sosnowiec, Poland
View Trial DetailsNCT07644871
Dark Spots, Hyperpigmentation
Irving, Texas, United States
View Trial DetailsNCT07501000
Hyperpigmentation, Pigmentation Disorders
Birmingham, Alabama, United States
View Trial Details